Invention Grant
- Patent Title: Use of nanoparticles for immunotherapy
-
Application No.: US16482125Application Date: 2018-01-31
-
Publication No.: US11369677B2Publication Date: 2022-06-28
- Inventor: Alf Lamprecht , Maryam Shetab Boushehri
- Applicant: Alf Lamprecht
- Applicant Address: DE Wesseling
- Assignee: Alf Lamprecht
- Current Assignee: Alf Lamprecht
- Current Assignee Address: DE Wesseling
- Agency: Grüneberg and Myers PLLC
- Priority: EP17154040 20170131
- International Application: PCT/EP2018/052433 WO 20180131
- International Announcement: WO2018/141810 WO 20180809
- Main IPC: A61K39/39
- IPC: A61K39/39 ; A61K9/16 ; A61P35/00 ; A61K39/00
Abstract:
A composition is for use as a medicament. The composition contains nanoparticles, wherein the nanoparticles contain a polymer selected from the group consisting of PLGA, PLA, PGA, PCL and poly(meth)acrylates, or a lipid. Further, the composition may contain nanoparticles made of a polymer selected from PLGA, amino alkyl methacrylate copolymers, methacrylic acid copolymers, methacrylic ester copolymers, and ammonio alkyl methacrylate copolymers.
Public/Granted literature
- US20190351053A1 USE OF NANOPARTICLES FOR IMMUNOTHERAPY Public/Granted day:2019-11-21
Information query
